TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancerRalph J. A. Maas, Harry Dolstra, Willemijn Hobo et al.|OncoImmunology|2020Cited by 69
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cellsJolien M.R. Van der Meer, Harry Dolstra, Ralph J. A. Maas et al.|Cancer Immunology Immunotherapy|2020Cited by 48
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancerRalph J. A. Maas, Harry Dolstra, Janneke S. Hoogstad‐van Evert et al.|Frontiers in Immunology|2024Cited by 21
CD34 <sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg <sup>null</sup> miceJolien M.R. Van der Meer, Harry Dolstra, Paul K.J.D. de Jonge et al.|OncoImmunology|2021Cited by 19
Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trialJanneke S. Hoogstad‐van Evert, Harry Dolstra, Paul K.J.D. de Jonge et al.|Gynecologic Oncology|2025Cited by 6